NewCardio Non Operating Income Net Other from 2010 to 2026

NWCI Stock  USD 0.0001  0.00  0.00%   
NewCardio's Non Operating Income Net Other is steady with stable movements from year to year. Non Operating Income Net Other is predicted to flatten to 0.00. As of now, NewCardio's Total Revenue is increasing as compared to previous years. The NewCardio's current Gross Profit is estimated to increase to about 126.9 K, while Selling General Administrative is projected to decrease to under 5.6 M. . View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check NewCardio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewCardio's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 89.26, Dividend Yield of 0.0 or Days Sales Outstanding of 40.43. NewCardio financial statements analysis is a perfect complement when working with NewCardio Valuation or Volatility modules.
  
Build AI portfolio with NewCardio Stock
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.

Currently Active Assets on Macroaxis

When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is there potential for Health Care Technology market expansion? Will NewCardio introduce new products? Factors like these will boost the valuation of NewCardio. Anticipated expansion of NewCardio directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
Understanding NewCardio requires distinguishing between market price and book value, where the latter reflects NewCardio's accounting equity. The concept of intrinsic value - what NewCardio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push NewCardio's price substantially above or below its fundamental value.
It's important to distinguish between NewCardio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NewCardio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NewCardio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.